We May Need More Than A Spoonful Of Sugar To Help Our Medicine Go Down
Filed under: FDA, Prescription Drugs, Proposed Legislation
Today CNNMoney reports that drug recalls quadrupled from 426 in 2008 to a record 1,742 in 2009. The recalls have been attributed to “manufacturing lapses” in raw material quality, labeling and packaging, and contamination. Generic and over-the-counter drugs have been affected the most. CNNMoney notes that the race to put generic products on the market and the pressure to cut costs have caused drug companies to
sometimes fail to spend enough time learning how best to make the drug…. And since generic and over the counter drugs aren’t as lucrative for drugmakers as prescription drugs, companies may not be investing enough resources to make high-quality, safe products.
One such cost-cutting measure involves outsourcing production to foreign manufacturing sites and this measure seems to have received the most attention. (Check out fellow blogger Jae W. Joo’s post on outsourcing.)
Earlier this month, Senator Michael Bennet (D-Colorado) introduced the Drug and Safety Accountability Act of 2010 which seeks to ensure the safety and efficacy of drugs sold in America, regardless of their manufacturing location. The bill would require, among other things, that:
- manufacturers have quality management plans which the FDA can inspect;
- manufacturers maintain supply chain documentation;
- the Secretary of Health and Human Services track facilities manufacturing drugs or active ingredients for the American market; and
- the FDA be given more power to ensure drug safety, including the authority to enact mandatory recalls for batches of drugs that pose risks and to assess civil penalties for violations of the Federal Food, Drug, and Cosmetic Act.
Click here for more details about the bill and here for Sen. Bennet’s own promotion of it. Sen. Bennet has lamented how:
[f]or too long, the FDA has lacked the proper authority to adequately safeguard our drug supply. Americans need to be able to trust that the drugs in their medicine cabinets are safe, no matter where they’re made.
A father of three, Sen. Bennet has said that the recent McNeil recall of over-the-counter children’s medicine spurred him into action.
Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson has issued a statement in response to the bill, saying that:
[t]he lifeline of America’s biopharmaceutical research companies is the safety and integrity of the products they develop. Brand-name pharmaceutical companies make tremendous investments in quality control systems and take extensive measures to help protect patient safety and to help prevent adulterated ingredients from entering into America’s prescription drug supply.
In addition, drug manufacturing for the U.S. market — regardless of where it occurs — is regulated under Good Manufacturing Practices (GMP) by the Food and Drug Administration (FDA). These GMP requirements help to assure the safety, quality and purity of drug ingredients that are used in the U.S. prescription drug supply.
The U.S. regulatory system for prescription drugs is the toughest and safest in the world….
Okay. But other people here don’t think so. (Click here to read a good opinion by Dr. Lynn Parry, Chair of the Colorado Prescription Project, on why this bill should pass.)
According to a recent Pew Prescription Project poll, less than 10% of Americans feel confident about medications manufactured in India and China. 89% of Americans support Congressional action to introduce new drug safety measures. How many of those people realize that approximately 80% of the materials used to make or package drugs sold in America comes from foreign sources? I didn’t, but then, is such high a percentage really that surprising?
Reading through the CNNMoney report, I was reminded a little of a scene from a seventh season episode of Friends:
Phoebe: It’s amazing! My headache is completely gone! What are those pills called?
Monica: Hexadrin.
Phoebe: Oh, I love you, Hexadrin! Oh look! It comes with a story!
Monica: No, Phoebe, those are, like, the side effects and stuff.
Phoebe: Say what?
Monica: You know, the possible side effects.
Phoebe: Oh my God! Dizziness, nervousness, drowsiness, facial swelling, nausea, headache… Headache! Vomiting, stomach bleeding, liver damage! Now, okay, I don’t recall any of this coming up when you gave me these little death capsules! Oh, I’m sorry, extra-strength death capsules!
Admittedly, the scene concerns how potential side effects can be worse than the problem being treated (and that’s a whole other blog post). Yet it’s also a reminder of how we can forget about the other potential hazards of these potent drugs, delivered in easy-to-swallow capsules/tablets/liquids, if there are quality control or other manufacturing issues. It’s as easy to forget as it is to pop them, well, like candy.




Posts from Health Reform Watch have been cited by media sources throughout the country, including The New York Times, Washington Post, L.A. Times, Kaiser Health News, The Health Care Blog, NPR's Planet Money Blog, Duke Univ. Med. Center News, American Health Line Alerts, BusinessWeek.com, Concurring Opinions, Balkinization, The New England Journal of Medicine, Harvard's Nieman Foundation for Journalism, Las Vegas Sun, Maggie Mahar, Ezra Klein, Tom Geoghegan, and the official homepage of the Office of the Democratic Majority Leader of the House of Representatives, Steny Hoyer.